Edition:
United States

Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

123.24USD
3:22pm EST
Change (% chg)

$-0.24 (-0.19%)
Prev Close
$123.48
Open
$123.82
Day's High
$128.78
Day's Low
$123.06
Volume
333,363
Avg. Vol
474,061
52-wk High
$196.11
52-wk Low
$119.37

ILMN.OQ

Chart for ILMN.OQ

About

Illumina, Inc. (Illumina) offers sequencing and array-based solutions for genetic analysis. The Company's products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The Company's customers include genomic research centers, academic institutions,... (more)

Overall

Beta: 1.15
Market Cap(Mil.): $18,139.21
Shares Outstanding(Mil.): 146.90
Dividend: --
Yield (%): --

Financials

  ILMN.OQ Industry Sector
P/E (TTM): 41.28 56.44 30.35
EPS (TTM): 2.99 -- --
ROI: 12.83 7.06 15.27
ROE: 21.23 10.66 16.60

Illumina wins dismissal of Scripps Institute patent lawsuit

A federal judge in San Diego has dismissed a lawsuit by the non-profit Scripps Research Institute accusing Illumina Inc of infringing a patent related to a type of genetic analysis tool.

Nov 23 2016

BRIEF-Illumina Q3 GAAP earnings per share $0.87

* Says continues to project Q4 revenue to be flat to slightly up compared to Q3

Nov 01 2016

BRIEF-German court issues preliminary injunction against Amedes Fetalis test

* German court issues preliminary injunction against Amedes Fetalis test for infringement of non-invasive prenatal screening patent

Oct 24 2016

BRIEF-Illumina announces preliminary revenue for Q3

* Illumina announces preliminary revenue for third quarter of fiscal year 2016

Oct 10 2016

BRIEF-Illumina increases size of board from eight to nine members

* Effective as of july 27, 2016, board of directors increased size of board from eight to nine members - sec filing Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 28 2016

BRIEF-Illumina names Philip Schiller to its board

* Says Schiller is currently Apple's senior vice president of worldwide marketing

Jul 28 2016

BRIEF-Illumina reports Q2 adj. earnings $0.86/shr

* Illumina reports financial results for second quarter of fiscal year 2016

Jul 26 2016

BRIEF-Enzo Biochem says Enzo Life Sciences reached settlement with Illumina that included payment of $21 mln to Enzo

* Co's unit, Enzo Life Sciences, has reached and finalized a settlement with Illumina that included a payment of $21 million to enzo

Jul 07 2016

BRIEF-Natera and Illumina extend supply agreement, broaden existing partnership to include oncology field

* Natera and Illumina extend supply agreement, broaden existing partnership to include oncology field Source text for Eikon: Further company coverage: )

Jun 29 2016

BRIEF-Natera, Illumina Inc enter 3rd amendment to supply agreement dated August 16, 2013

* On June 8, 2016, co and Illumina Inc entered into third amendment to a supply agreement dated August 16, 2013

Jun 13 2016

Earnings vs. Estimates